Literature DB >> 17618677

In vitro study of the hypercoagulable state in multiple myeloma patients treated or not with thalidomide.

Anna D Petropoulou1, Grigoris T Gerotziafas, Meyer M Samama, Mohamed Hatmi, Francine Rendu, Ismail Elalamy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17618677     DOI： 10.1016/j.thromres.2007.05.016

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  4 in total

1.  Patients With Multiple Myeloma Have a Disbalanced Whole Blood Thrombin Generation Profile.

Authors:  Li Li; Mark Roest; Yaqiu Sang; Jasper A Remijn; Rob Fijnheer; Karel Smit; Dana Huskens; Jun Wan; Bas de Laat; Joke Konings
Journal:  Front Cardiovasc Med       Date:  2022-06-27

2.  Thalidomide effect in endothelial cell of acute radiation proctitis.

Authors:  Ki-Tae Kim; Hiun-Suk Chae; Jin-Soo Kim; Hyung-Keun Kim; Young-Seok Cho; Whang Choi; Kyu-Yong Choi; Sang-Young Rho; Suk-Jin Kang
Journal:  World J Gastroenterol       Date:  2008-08-14       Impact factor: 5.742

3.  Hemostatic changes after 1 month of thalidomide and dexamethasone therapy in patients with multiple myeloma.

Authors:  Marta Robak; Jacek Treliński; Krzysztof Chojnowski
Journal:  Med Oncol       Date:  2012-07-07       Impact factor: 3.064

4.  Plasma Levels of Vascular Endothelial Growth Factor and Selected Hemostatic Parameters in Association With Treatment Response in Multiple Myeloma.

Authors:  Juraj Sokol; Matej Hrncar; Frantisek Nehaj; Jan Stasko
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.